Journal Title：Drug Delivery And Translational Research

The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions.

Research focused on the following areas of translational drug delivery research will be considered for publication in the journal.

Designing and developing novel drug delivery systems, with a focus on their application to disease conditions;

Preclinical and clinical data related to drug delivery systems;

Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes

Short-term and long-term biocompatibility of drug delivery systems, host response;

Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering;

Image-guided drug therapy,

Nanomedicine;

Devices for drug delivery and drug/device combination products.

In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.

該期刊為專注于藥物輸送轉化方面的高質量研究的科學出版提供了一個獨特的論壇。合理開發的有效給藥系統可能會影響不同疾病條件下的臨床結果。

專注于以下轉化藥物輸送研究領域的研究將被考慮在期刊上發表。

設計和開發新型藥物輸送系統，重點是其在疾病條件下的應用；

與藥物輸送系統相關的臨床前和臨床數據；

藥物分布、藥代動力學、清除率，與傳統給藥相比，藥物輸送系統顯示出有益的結果

藥物輸送系統的短期和長期生物相容性、宿主反應；

再生醫學和組織工程中用于干細胞分化的含有生長因子的生物材料；

圖像引導藥物治療，

納米醫學；

藥物輸送裝置和藥物/裝置組合產品。

除了原始全文論文外，該期刊包含社論、未來會議報告、研究亮點以及與控制釋放協會活動有關的公告。

Drug Delivery And Translational Research創刊于2011年，由Springer US出版商出版，收稿方向涵蓋MEDICINE, RESEARCH & EXPERIMENTALPHARMACOL - PHARMACOLOGY & PHARMACY全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 ，影響因子指數5.7，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。